CC

Claudine Clucas

Senior Research Associate at Evidera

Claudine Clucas is a seasoned research professional with extensive experience in the field of psychology and research methodologies. Currently serving as a Senior Research Associate at Evidera since June 2022, Claudine previously held roles as Research Scientist and Senior Research Associate at Clinical Outcomes Solutions from June 2020 to June 2022. Prior to that, Claudine was a Senior Lecturer and Lecturer at the University of Chester for nearly nine years. Claudine's career began as a Research Psychologist/Statistician at UCL from November 2008 to August 2011. Educational credentials include a Doctor of Philosophy (PhD) in Psychology from the University of Bristol, a Master of Science (MSc) in Research Methods from the University of Oxford, and a Bachelor's degree in Psychology from the University of Connecticut.

Location

Folkestone, United Kingdom

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Evidera

1 followers

Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.